Floatz logo

.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO-

Pediatric Hepatoblastoma

Federal Research Institute of Pediatric Hematology, Oncology and ImmunologySmall moleculePhase 2/3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

44 Active assets in the Pediatric Hepatoblastoma cohort.

Asset / SponsorPhaseRating
Eloxatin
Children's Oncology Group
Phase 3BB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 2BB
(+)-VINCRISTINE
University of Birmingham
Phase 3BB
ETOPOSIDE
Children's Oncology Group
Phase 3BB
Carboplatin
Children's Oncology Group
Phase 3BB

View all 50 →

Same molecule, other indications

.GAMMA.-CYCLODEXTRIN, 6A,6B,6C,6D,6E,7F,6G,6H-OCTAKIS-S-(2-CARBOXYETHYL)-6A,6B,6C,6D,6E,7F,6G,6H-OCTATHIO- is also rated in:

neuromuscular junction diseaseDormant
A
Indicative ·
84 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
69 / 100
View asset →
Surgical ConditionsDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →